FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2109309944> ?p ?o ?g. }

• W2109309944 endingPage "680" @default.
• W2109309944 startingPage "671" @default.
• W2109309944 abstract "p21-activated kinase 1 (Pak1) phosphorylates many proteins in both normal and transformed cells. Its ability to phosphorylate and thereby activate the estrogen receptor alpha (ERalpha) potentially limits the effectiveness of antiestrogen treatment in breast cancer. Here we studied associations between Pak1 expression and subcellular localization in tumor cells and tamoxifen resistance.Pak1 protein expression was evaluated in 403 primary breast tumors from premenopausal patients who had been randomly assigned to 2 years of adjuvant tamoxifen or no treatment. Tamoxifen response was evaluated by comparing recurrence-free survival in relation to Pak1 and ERalpha expression in untreated versus tamoxifen-treated patients. Tamoxifen responsiveness of human MCF-7 breast cancer cells that inducibly expressed constitutively active Pak1 or that transiently overexpressed wild-type Pak1 (Wt-Pak1) or Pak1 that lacked functional nuclear localization signals (Pak1DeltaNLS) was evaluated by analyzing cyclin D1 promoter activation and protein levels as markers for ERalpha activation. The response to tamoxifen in relation to Pak1 expression was analyzed in naturally tamoxifen-resistant Ishikawa human endometrial cancer cells. All statistical tests were two-sided.Among patients who had ERalpha-positive tumors with low Pak1 expression, those treated with tamoxifen had better recurrence-free survival than those who received no treatment (hazard ratio [HR] = 0.502, 95% confidence interval [CI] = 0.331 to 0.762; P = .001) whereas there was no difference in recurrence-free survival between treatment groups for patients whose tumors had high cytoplasmic (HR = 0.893, 95% CI = 0.420 to 1.901; P = .769) or any nuclear Pak1 expression (HR = 0.955, 95% CI = 0.405 to 2.250; P = .916). In MCF-7 cells, overexpression of Wt-Pak1, but not of Pak1DeltaNLS, compromised tamoxifen response by stimulating cyclin D1 expression. Treatment of Ishikawa cells with tamoxifen led to an increase in the amount of nuclear Pak1 and Pak1 kinase activity, suggesting that tamoxifen, to some extent, regulates Pak1 expression.Our data support a role for Pak1, particular Pak1 localized to the nucleus, in ERalpha signaling and in tamoxifen resistance." @default.
• W2109309944 created "2016-06-24" @default.
• W2109309944 creator A5023261075 @default.
• W2109309944 creator A5029764881 @default.
• W2109309944 creator A5044198521 @default.
• W2109309944 creator A5046588878 @default.
• W2109309944 creator A5069640338 @default.
• W2109309944 creator A5075000175 @default.
• W2109309944 date "2006-05-17" @default.
• W2109309944 modified "2023-10-14" @default.
• W2109309944 title "Association Between Pak1 Expression and Subcellular Localization and Tamoxifen Resistance in Breast Cancer Patients" @default.
• W2109309944 cites W1539701480 @default.
• W2109309944 cites W1562190372 @default.
• W2109309944 cites W1970609355 @default.
• W2109309944 cites W1979400580 @default.
• W2109309944 cites W1985462906 @default.
• W2109309944 cites W1988242406 @default.
• W2109309944 cites W1998232305 @default.
• W2109309944 cites W2003597023 @default.
• W2109309944 cites W2009461629 @default.
• W2109309944 cites W2019729084 @default.
• W2109309944 cites W2023503727 @default.
• W2109309944 cites W2026251993 @default.
• W2109309944 cites W2030140160 @default.
• W2109309944 cites W2034546318 @default.
• W2109309944 cites W2041966576 @default.
• W2109309944 cites W2054697866 @default.
• W2109309944 cites W2071901592 @default.
• W2109309944 cites W2080421196 @default.
• W2109309944 cites W2081491080 @default.
• W2109309944 cites W2090342862 @default.
• W2109309944 cites W2095260737 @default.
• W2109309944 cites W2103164402 @default.
• W2109309944 cites W2106984286 @default.
• W2109309944 cites W2123681374 @default.
• W2109309944 cites W2128605357 @default.
• W2109309944 cites W2131206883 @default.
• W2109309944 cites W2134574409 @default.
• W2109309944 cites W2139451284 @default.
• W2109309944 cites W2147371405 @default.
• W2109309944 cites W2171351808 @default.
• W2109309944 doi "https://doi.org/10.1093/jnci/djj185" @default.
• W2109309944 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/16705121" @default.
• W2109309944 hasPublicationYear "2006" @default.
• W2109309944 type Work @default.
• W2109309944 sameAs 2109309944 @default.
• W2109309944 citedByCount "179" @default.
• W2109309944 countsByYear W21093099442012 @default.
• W2109309944 countsByYear W21093099442013 @default.
• W2109309944 countsByYear W21093099442014 @default.
• W2109309944 countsByYear W21093099442015 @default.
• W2109309944 countsByYear W21093099442016 @default.
• W2109309944 countsByYear W21093099442017 @default.
• W2109309944 countsByYear W21093099442018 @default.
• W2109309944 countsByYear W21093099442019 @default.
• W2109309944 countsByYear W21093099442020 @default.
• W2109309944 countsByYear W21093099442021 @default.
• W2109309944 countsByYear W21093099442022 @default.
• W2109309944 countsByYear W21093099442023 @default.
• W2109309944 crossrefType "journal-article" @default.
• W2109309944 hasAuthorship W2109309944A5023261075 @default.
• W2109309944 hasAuthorship W2109309944A5029764881 @default.
• W2109309944 hasAuthorship W2109309944A5044198521 @default.
• W2109309944 hasAuthorship W2109309944A5046588878 @default.
• W2109309944 hasAuthorship W2109309944A5069640338 @default.
• W2109309944 hasAuthorship W2109309944A5075000175 @default.
• W2109309944 hasBestOaLocation W21093099441 @default.
• W2109309944 hasConcept C121608353 @default.
• W2109309944 hasConcept C126322002 @default.
• W2109309944 hasConcept C134018914 @default.
• W2109309944 hasConcept C143998085 @default.
• W2109309944 hasConcept C184235292 @default.
• W2109309944 hasConcept C24901178 @default.
• W2109309944 hasConcept C2776067312 @default.
• W2109309944 hasConcept C2777176818 @default.
• W2109309944 hasConcept C502942594 @default.
• W2109309944 hasConcept C530470458 @default.
• W2109309944 hasConcept C71924100 @default.
• W2109309944 hasConcept C84606932 @default.
• W2109309944 hasConcept C86803240 @default.
• W2109309944 hasConcept C95444343 @default.
• W2109309944 hasConceptScore W2109309944C121608353 @default.
• W2109309944 hasConceptScore W2109309944C126322002 @default.
• W2109309944 hasConceptScore W2109309944C134018914 @default.
• W2109309944 hasConceptScore W2109309944C143998085 @default.
• W2109309944 hasConceptScore W2109309944C184235292 @default.
• W2109309944 hasConceptScore W2109309944C24901178 @default.
• W2109309944 hasConceptScore W2109309944C2776067312 @default.
• W2109309944 hasConceptScore W2109309944C2777176818 @default.
• W2109309944 hasConceptScore W2109309944C502942594 @default.
• W2109309944 hasConceptScore W2109309944C530470458 @default.
• W2109309944 hasConceptScore W2109309944C71924100 @default.
• W2109309944 hasConceptScore W2109309944C84606932 @default.
• W2109309944 hasConceptScore W2109309944C86803240 @default.
• W2109309944 hasConceptScore W2109309944C95444343 @default.
• W2109309944 hasIssue "10" @default.
• W2109309944 hasLocation W21093099441 @default.
• W2109309944 hasLocation W21093099442 @default.

• next